The novel μ-Opioid receptor antagonist, [N-Allyl-Dmt1] Endomorphin-2, attenuates the enhancement of GABAergic neurotransmission by ethanol

Alcohol and Alcoholism

Volumn 44, Issue 1, 2009, Pages 13-19

  Li, Qiang ^a,b   Okada, Yoshio ^c   Marczak, Ewa ^d   Wilson, Wilkie A ^a,b   Lazarus, Lawrence H ^d   Swartzwelder, H S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c KOBE GAKUIN UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ENDOMORPHIN 2; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALTREXONE; OPIATE ANTAGONIST; (N ALLYL DMT(1))ENDOMORPHIN 2; (N-ALLYL-DMT(1))ENDOMORPHIN-2; 4 AMINOBUTYRIC ACID; CENTRAL DEPRESSANT AGENT; OLIGOPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING; SEDATION; SYNAPTIC TRANSMISSION; TRANQUILIZING ACTIVITY; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; KINETICS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; KINETICS; MALE; OLIGOPEPTIDES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SYNAPTIC TRANSMISSION;

EID: 58149131305     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agn085     Document Type: Article

References (46)

1. Anton RF, Moak DH, Waid LR et al. (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. Am J Psychiatry 156:1758-64.
2. Benjamin D, Grant ER, Pohorecky LA. (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 621:137-40.
3. Browning KN, Kalyuzhny AE, Travagli RA. (2002) Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Neurosci 22:2998-3004.
4. Cha YM, Li Q, Wilson WA et al. (2006) Sedative and GABAergic effects of ethanol on male and female rats. Alcohol Clin Exp Res 30:113-8.
5. Ciccocioppo R, Martin-Fardon R, Weiss F. (2002) Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27:391-9.
6. Crain BJ, Chang KJ, McNamara JO. (1986) Quantitative autoradiographic analysis of mu and delta opioid binding sites in the rat hippocampal formation. J Comp Neurol 246:170-80.
7. Croop RS, Faulkner EB, Labriola DF. (1997) The safety profile of naltrexone in the treatment of alcoholism. Arch Gen Psychiatry 54:1130-5.
8. De Waele JP, Kiianmaa K, Gianoulakis C. (1994) Spontaneous and ethanol-stimulated in vitro release of β-endorphin by the hypothalamus of AA and ANA rats. Alcohol Clin Exp Res 18:1468-73.
9. De Waele JP, Papachristou DN, Gianoulakis C.(1992) The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J Pharmacol Exp Ther 261:788-94.
10. Di Chiara G.(1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38 95-137.
11. Drake CT, Milner TA. (2002) Mu opioid receptors are in discrete hippocampal interneuron subpopulation. Hippocampus 12:119-36.
12. Froehlich JC. (1995) Genetic factors in alcohol self-administration. J Clin Psychiatry 56(Suppl 7):15-23.
13. Gianoulakis C. (2004) Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 4:39-50.
14. Glatzer NR, Smith BN. (2005) Modulation of synaptic transmission in the rat nucleus of the solitary tract by endomorphin-1. J Neurophysiol 93:2530-40.
15. Gonzales RA, Weiss F. (1998) Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 18:10663-71.
16. Hall FS, Sora I, Uhl GR. (2001) Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology 154:43-9.
17. Heilig M, Egli M. (2006) Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms. Pharmacol Ther 111:855-76.
18. Heinz A, Reimold M, Wrase J et al. (2005) Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: A positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62:57-64.
19. Herz A. (1997) Endogenous opioid systems and alcohol addition. Psychopharmacology 129:99-111.
20. Honkanen AL, Vilamo K, Wegelius M et al. (1996) Alcohol drinking is reduced by a mu-1 but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Eur J Pharmacol 304:7-13.
21. Hyytia P. (1993) Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45 697-791.
22. Hyytia P, Kiianmaa K. (2001) Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol Clin Exp Res 25: 25-33.
23. Inoue H. (2000) Effects of naltrexone on the accumulation of L-3,4-dihydroxyphenylalanine and 5-hydroxy-L-tryptophan and on the firing rate induced by acute ethanol administration. Eur J Pharmacol 406:375-80.
24. 1]endomorphin-1. Pharmacol Biochem Behav 84:252-8.
25. Jinsmaa Y, Okada Y, Tsuda Y et al. (2004) Novel 2′,6′-dimethyl-L-tyrosine-containing pyrazinone opioid mimetic mu-agonists with potent antinociceptive activity in mice. J Pharmacol Exp Ther 309:432-8.
26. Juarez J, Eliana DT. (2007) Alcohol consumption is enhanced after naltrexone treatment. Alcohol Clin Exp Res 31:260-4.
27. Krystal JH, Cramer JA, Krol WF et al. (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734-9.
28. Li T, Jinsmaa Y, Nedachi M et al. (2007). Transformation of muopioid receptor agonists into biologically potent μ-opioid receptor antagonists. Bioorg Med Chem 15:1237-51.
29. Li XW, Li TK, Froehlich JC. (1998) Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference. Brain Res 794:35-47.
30. Li T, Tsuda Y, Minoura K et al. (2006a) Enantioselective synthesis of a phenylalanine library containing alkyl groups on the aromatic moiety: Confirmation of stereostructure by X-ray analysis. Chem Pharm Bull 54:873-7.
31. A receptor-mediated IPSCs to ethanol. Alcohol Clin Exp Res 27:2017-22
32. Li Q, Wilson WA, Swartzwelder HS. (2006b) Developmental differences in the sensitivity of spontaneous and miniature IPSCs to ethanol. Alcohol Clin Exp Res 30:119-26
33. Lupica CR. (1995) Delta and mu enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. J Neurosci 15:737-49.
34. 1]-endom orphins are μ-opioid receptor antagonists lacking inverse agonist properties. J Pharmacol Exp Ther 323 374-80.
35. B receptor synaptic function in hippocampal CA1. J Neurophysiol 97:2301-11.
36. O'Malley SS, Krishnan-Sarin S, Farren C et al. (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology 160:19-29.
37. A receptor-mediated responses in cerebral cortical neurons in rat brain slices. Brain Res 595:220-7.
38. Roberts AJ, McDonald JS, Heyser CJ et al. (2000) mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 293:1002-8.
39. Schulz R, Wuster M, Duka T et al. (1980) Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology 68:221-7.
40. Siggins GR, Zieglgansberger W. (1981). Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. Proc Natl Acad Sci USA 78:5235-9.
41. Srisurapanont M, Jarusuraisin N. (2005). Opioid antagonists for alcohol dependence (review). The Cochrane Collaboration. New York: Wiley, 1-54.
42. Stromberg MF, Casale M, Volpicelli L et al. (1998) A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol 15:281-9.
43. Ulm RR, Volpicelli JR, Volpicelli LA. (1995) Opiates and alcohol self-administration in animals. J Clin Psychiatry 56(Suppl 7):5-14.
44. Venkatesan P, Wang J, Evans C et al. (2002) Endomorphin-2 inhibits GABAergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus. Neuroscience 113:975-83.
45. A synapses onto rat hippocampal CA1 pyramidal neurons. J Neurophysiol 77:1306-12.
46. Zadina JE, Hackler L, Ge LJ et al. (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386 499-502.